SIFI SpA - Company Profile
Powered by 
All the data and insights you need on SIFI SpA in one report.
$295
- Save hours of research time and resources with
our up-to-date SIFI SpA Strategy Report
- Understand SIFI SpA position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
SIFI SpA (SIFI) is an ophthalmic company. It develops, manufactures, and markets pharmaceutical products, diagnostic instruments, and surgical equipment for the prevention and treatment of ocular pathologies. SIFI develops its products in various dosage forms including ointments, eye drops, pills, and capsules. Its products find application in the areas of corneal abrasions, cataracts, glaucoma, infections, inflammation, corneal lesions, periocular hygiene, dry eye, and retinopathies. It conducts research in the areas of diagnostics and surgery. SIFI operates directly in Italy, Spain, France, Romania, Mexico, and Turkey. SIFI is headquartered in Catania, Italy.
Headquarters
Italy
Address
Via Ercole Patti, 36, Lavinaio – Aci S, Antonio, Catania, Sicilia, 95025
Website
www.sifigroup.com
Telephone
39 095 7922111
No of Employees
500
Industry
Pharmaceuticals and Healthcare
SIFI SpA premium industry data and analytics
Products and Services
| Products | Brands |
|---|---|
| Ophthalmic Therapeutic Products | Colbiocin |
| Ophthalmic Surgical Devices | Genticol |
| Food Supplements - Nutraceuticals | Pensulvit |
| XYZ | XYZ |
| XYZ | XYZ |
| XYZ | XYZ |
History
History section provides information on new products, mergers, acquisitions, expansions, approvals, and many more key events.
| Year | Event | Description |
|---|---|---|
| 2024 | Contracts/Agreements | In February, the company signed a joint venture agreement with Globe MedEx. |
| 2023 | Contracts/Agreements | In October, the company entered into an agreement with AffaMed Technologies to give improved intermediate vision and similar distant vision. |
| 2023 | Contracts/Agreements | In January, the company partnered with Avanzanite Bioscience to commercialize and distribute AKANTIOR (polihexanide) in 26 Countries within the European Economic Area and Switzerland. |
Competitor Comparison
| Key Parameters | SIFI SpA | Alfa Intes srl | Bruschettini Srl | LTL S.p.A | Optikon 2000 SpA |
|---|---|---|---|---|---|
| Headquarters | Italy | Italy | Italy | Italy | Italy |
| City | Catania | Casoria | Genova | - | Roma |
| State/Province | Sicilia | Campania | Liguria | Friuli-Venezia Giulia | Lazio |
| No. of Employees | 500 | - | - | - | 100 |
| Entity Type | Private | Private | Private | Private | Private |
Executives
| Name | Position | Board | Since | Age |
|---|---|---|---|---|
| Fabrizio Chines | Chief Executive Officer; Chairman | Executive Board | - | - |
| Andrea Quaglino | Chief Financial Officer | Senior Management | 2018 | - |
| Jelle Kleijn, PhD | Head - Acanthamoeba Keratitis | Senior Management | 2020 | - |
| Fabrizio Folco | Manager - Italy | Operational Management | - | - |
| Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer